IL6 and bacterial infectious disease: To evaluate the effect of the interleukin-6 (IL-6) inhibitor tocilizumab on bacterial infection-associated bone resorption around implants during osseointegration, they placed Dentium implants in the anterior mandible of New Zealand white rabbits.